ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,588Medicare Part D Prescriptions Filled, Including Refills

Rank: 219 out of 2343

$731K Total Retail Price of All Prescriptions

Rank: 295 out of 2343

543 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 543 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 543 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 12,195 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 645 584 1 1
AMLODIPINE BESYLATE 411 371 2 5
OMEPRAZOLE 409 342 3 4
WARFARIN SODIUM 399 319 4 8
METOPROLOL TARTRATE 382 334 5 7
ATENOLOL 371 345 6 12
HYDROCODONE-ACETAMINOPHEN 315 177 S3 7 13
HYDROCHLOROTHIAZIDE 304 270 8 11
LISINOPRIL 294 263 9 3
LEVOTHYROXINE SODIUM 278 241 10 2
METOPROLOL SUCCINATE 260 248 11 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 248 197 12 42
FUROSEMIDE 233 212 13 6
ATORVASTATIN CALCIUM 219 208 14 10
POTASSIUM CHLORIDE 177 146 15 18
ISOSORBIDE MONONITRATE ER 175 150 16 32
METFORMIN HCL 168 131 17 9
CLOPIDOGREL 165 151 18 26
AMLODIPINE BESYLATE-BENAZEPRIL 157 154 19 59
PANTOPRAZOLE SODIUM 144 120 20 22
TAMSULOSIN HCL 142 119 21 29
COUMADIN 120 115 22 216
RANITIDINE HCL 119 88 23 43
PLAVIX 117 104 24 38
KLOR-CON M20 115 77 25 44
DONEPEZIL HCL 115 111 25 21
GLYBURIDE 114 102 R 27 62
GLIMEPIRIDE 110 89 28 45
AZITHROMYCIN 108 86 29 39
PRAVASTATIN SODIUM 107 91 30 15
NATEGLINIDE 106 106 31 255
DIOVAN 104 78 32 23
BENAZEPRIL HCL 103 92 33 113
CITALOPRAM HBR 100 73 34 17
TRAMADOL HCL-ACETAMINOPHEN 98 98 35 199
DIOVAN HCT 94 86 36 63
NIASPAN 93 72 37 141
OXYCODONE-ACETAMINOPHEN 90 59 S2 38 49
ALENDRONATE SODIUM 87 87 39 28
RISPERIDONE 85 64 40 61
NAMENDA 82 80 41 36
ATENOLOL-CHLORTHALIDONE 82 68 41 190
LANTUS 81 73 43 51
DICLOFENAC SODIUM 81 64 43 155
CRESTOR 80 66 45 30
ZETIA 80 52 45 52
METHYLPREDNISOLONE 80 62 45 122
GABAPENTIN 78 49 48 16
NOVOLOG 78 51 48 110
CELEBREX 78 55 48 71
FINASTERIDE 77 77 51 80
DOXAZOSIN MESYLATE 75 75 52 98
LOSARTAN-HYDROCHLOROTHIAZIDE 72 72 53 64
CLONIDINE HCL 72 72 53 70
NEXIUM 72 46 53 33
LOSARTAN POTASSIUM 72 72 53 19
BISOPROLOL-HYDROCHLOROTHIAZIDE 71 71 57 151
FELODIPINE ER 70 70 58 116
RAMIPRIL 70 70 58 90
ZOLPIDEM TARTRATE 69 45 60 24
AMOX TR-POTASSIUM CLAVULANATE 68 54 61 160
CARVEDILOL 68 54 61 27
DILTIAZEM 24HR CD 67 67 63 83
OXYCONTIN 65 41 S2 64 138
NOVOLOG MIX 70-30 64 40 65 257
AMITRIPTYLINE HCL 63 42 R 66 117
FENTANYL 62 35 S2 67 69
FLUOXETINE HCL 61 59 68 82
CLOTRIMAZOLE-BETAMETHASONE 60 42 69 127
GEMFIBROZIL 59 55 70 133
ENALAPRIL MALEATE 59 59 70 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 41 72 120
SPIRONOLACTONE 58 53 72 65
DILTIAZEM 24HR ER 58 45 72 76
TRAZODONE HCL 58 58 72 53
SPIRIVA 55 54 76 48
LEVETIRACETAM 55 43 76 104
PROMETHAZINE HCL 54 40 R 78 222
LIPITOR 54 40 78 78
DIVALPROEX SODIUM 53 36 80 105
SYNTHROID 52 37 81 40
ADVAIR DISKUS 52 40 81 34
ALLOPURINOL 52 45 81 31
GLYBURIDE-METFORMIN HCL 51 40 R 84 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.